2017
DOI: 10.3174/ajnr.a5463
|View full text |Cite
|
Sign up to set email alerts
|

Posttreatment Infarct Volumes when Compared with 24-Hour and 90-Day Clinical Outcomes: Insights from the REVASCAT Randomized Controlled Trial

Abstract: BACKGROUND AND PURPOSE: Endovascular therapy has become the standard of care for patients with disabling anterior circulation ischemic stroke due to proximal intracranial thrombi. Our aim was to determine whether the beneficial effect of endovascular treatment on functional outcome could be explained by a reduction in posttreatment infarct volume in the Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours (REVASCAT) trial.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
31
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(31 citation statements)
references
References 24 publications
0
31
0
Order By: Relevance
“…Our results indicate that total ischemic volume is a major determinant for acute symptom severity in LVO patients measured by the NIHSS. Notably, there is also an established linear relationship between NIHSS after 24 h and post-treatment infarction volume hinting toward similar mechanisms moderating morphology and symptom severity in the hyperacute and post-therapeutic acute stroke phase ( 26 ). We also observed significant association of the clot burden score with NIHSS on admission similar to other studies ( 8 , 9 ).…”
Section: Discussionmentioning
confidence: 99%
“…Our results indicate that total ischemic volume is a major determinant for acute symptom severity in LVO patients measured by the NIHSS. Notably, there is also an established linear relationship between NIHSS after 24 h and post-treatment infarction volume hinting toward similar mechanisms moderating morphology and symptom severity in the hyperacute and post-therapeutic acute stroke phase ( 26 ). We also observed significant association of the clot burden score with NIHSS on admission similar to other studies ( 8 , 9 ).…”
Section: Discussionmentioning
confidence: 99%
“…Considering this fact, the DSC of 72.5% is suggesting a satisfactory level of agreement between two segmentations [30]. In addition, the infarct and hemorrhage volume is more important compared to the computational metrics, such as DSC, MAD, and MAXD, if clinical outcome is considered [2], [3]. The additional analyses using Pearson correlation and Bland-Altman analyses in this study demonstrated a strong correlation and minimal error range between the algorithm segmented and manually contoured volume, demonstrating the clinical benefits of this study.…”
Section: Discussionmentioning
confidence: 99%
“…Recent randomized clinical trials revolutionized stroke care by confirming clinical benefit of modern endovascular therapy (EVT) in acute ischemic stroke (AIS) patients due to proximal anterior circulation occlusion [1]. A recent study showed that the beneficial effect of EVT on clinical outcomes could be explained by a reduction in post-treatment cerebral infarct volume (CIV) [2], [3], measured on follow-up non-contrast CT (NCCT) scans. Post-treatment CIV of AIS patients in NCCT typically includes ischemic infarct only.…”
Section: Introductionmentioning
confidence: 99%
“…Studies have shown that patients with low mRS scores at 90 days may have smaller infarctions after endovascular therapy but have higher NIHSS scores at 24/48 h. This may be related to whether the infarction is located in the eloquent brain or not. 31 Ganesh et al found that patients with large posttreatment infarct volume (PIV) rarely developed serious adverse events. 32 This result is consistent with our findings.…”
Section: Discussionmentioning
confidence: 99%